Retour
Fourchette du Jour
0,06 €
0,06 €
Fourchette 52 Semaines
0,06 €
0,10 €
Volume
1 680
Moyenne 50J / 200J
0,07 €
/
0,08 €
Clôture Précédente
0,06 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 0,0 | 0,4 |
| P/B | 0,0 | 2,9 |
| ROE % | 14,7 | 3,7 |
| Net Margin % | 9,9 | 3,9 |
| Rev Growth 5Y % | 9,0 | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2028 |
0,00 €
0,00 € – 0,00 €
|
44000 B | 0 |
| FY2027 |
93,45 €
88,41 € – 97,20 €
|
41000 B | 1 |
| FY2026 |
84,33 €
79,78 € – 87,72 €
|
38000 B | 1 |
Points Clés
Revenue grew 9,00% annually over 5 years — modest growth
Earnings grew 17,13% over the past year
ROE of 14,66% — decent returns on equity
Debt/Equity of 0,02 — conservative balance sheet
Generating 3,53T in free cash flow
Cash machine — converts 109,08% of earnings into free cash flow
Croissance
Revenue Growth (5Y)
9,00%
Revenue (1Y)7,16%
Earnings (1Y)17,13%
FCF Growth (3Y)10,42%
Qualité
Return on Equity
14,66%
ROIC13,07%
Net Margin9,93%
Op. Margin12,47%
Sécurité
Debt / Equity
0,02
Current Ratio4,11
Interest Coverage72,22
Valorisation
P/E Ratio
0,00
P/B Ratio0,00
EV/EBITDA-1,02
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 7,16% | Revenue Growth (3Y) | 6,19% |
| Earnings Growth (1Y) | 17,13% | Earnings Growth (3Y) | -2,12% |
| Revenue Growth (5Y) | 9,00% | Earnings Growth (5Y) | 4,35% |
| Profitability | |||
| Revenue (TTM) | 32,63T | Net Income (TTM) | 3,24T |
| ROE | 14,66% | ROA | 11,01% |
| Gross Margin | 39,71% | Operating Margin | 12,47% |
| Net Margin | 9,93% | Free Cash Flow (TTM) | 3,53T |
| ROIC | 13,07% | FCF Growth (3Y) | 10,42% |
| Safety | |||
| Debt / Equity | 0,02 | Current Ratio | 4,11 |
| Interest Coverage | 72,22 | Dividend Yield | 0,02% |
| Valuation | |||
| P/E Ratio | 0,00 | P/B Ratio | 0,00 |
| P/S Ratio | 0,00 | PEG Ratio | 1,25 |
| EV/EBITDA | -1,02 | Dividend Yield | 0,02% |
| Market Cap | 2,67B | Enterprise Value | -4,16T |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 32,63T | 30,45T | 28,93T | 26,26T | 23,11T |
| Net Income | 3,24T | 2,77T | 3,38T | 3,18T | 2,73T |
| EPS (Diluted) | 70,22 | 59,81 | 72,71 | 67,92 | 58,31 |
| Gross Profit | 12,96T | 11,55T | 11,70T | 11,28T | 10,25T |
| Operating Income | 4,07T | 3,63T | 4,49T | 4,16T | 3,64T |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 29,43T | 27,06T | 27,24T | 25,67T | 22,56T |
| Total Liabilities | 4,84T | 3,94T | 5,14T | 4,40T | 4,29T |
| Shareholders' Equity | 22,79T | 21,42T | 20,39T | 19,58T | 17,41T |
| Total Debt | 559,22B | 618,54B | 1,17T | 626,16B | 1,16T |
| Cash & Equivalents | 4,72T | 3,23T | 3,95T | 6,22T | 5,21T |
| Current Assets | 17,19T | 15,92T | 16,71T | 15,71T | 13,08T |
| Current Liabilities | 4,19T | 3,24T | 4,43T | 3,53T | 3,18T |
Scores de Stratégies
This stock passed the criteria for 3 strategies
Score = fit strength (0–100)
Rank = position among all matches
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026
Entré
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entré
Defensive Investing (Benjamin Graham)
Mar 24, 2026